Press release
Booming Gastroesophageal Reflux Disease Therapeutics Market: Projected to reach $7.89 billion by 2029 with a CAGR of 6.5%
Gastroesophageal Reflux Disease Therapeutics Market Size
What Is The Projected Market Size Of The Global Gastroesophageal Reflux Disease Therapeutics Market And Its Growth Rate?
• The market size has grown steadily in recent years, from $5.93 billion in 2024 to $6.14 billion in 2025 at a CAGR of 3.6% due to prevalent lifestyle changes and increase in obesity rates.
• The market is expected to grow significantly in the forthcoming years reaching $7.89 billion in 2029 at a CAGR of 6.5% driven by demand for innovative therapies, growing geriatric population, personalized medicine, and emergence of biologics.
What Is Driving The Growth In The Gastroesophageal Reflux Disease Therapeutics Market?
The prevalence of gastroesophageal reflux disease is the primary driver propelling the progression of this market. Characterized by the backflow of stomach acid into the esophagus, it is a chronic condition leading to considerable heartburn and potential complications. As per an article published by WebMed in September 2022, over 60 million American adults cope with heartburn at least once a month, and over 15 million daily. These findings have brought to light the significant economic burden faced by the U.S. due to direct and indirect expenditures linked to GERD, one of the most often diagnosed digestive illnesses, thus, paving the way for market expansion.
Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12058&type=smp
Who Are The Key Players Driving Gastroesophageal Reflux Disease Therapeutics Market Growth?
• Pfizer Inc.
• Johnson and Johnson
• Novartis AG
• Sanofi S.A.
• AstraZeneca plc
• Medtronic PLC
• GlaxoSmithKline plc
• Eisai Co. Ltd.
What Are The Key Trends In The Gastroesophageal Reflux Disease Therapeutics Market?
• Alternative therapies and mind-body practices
• Expanded research into gut health
• Advent of patient-centric care models
• Targeted marketing for gerd awareness
• Integration of digital health tools
What Are The Segments Of The Global Gastroesophageal Reflux Disease Therapeutics Market?
• By Type: Branded, Generic
• By Drug Class: Antacids, Proton Pump Inhibitors, Histamine Blockers, Pro-Kinetic Agents, Other Drugs Class
• By Distribution Channel: Hospital Pharmacy, Drug Stores, General Stores, Super markets
• By Application: Crohn's Disease, Gastroesophageal Reflux Disease (GERD), Ulcerative Colitis
Which Region Leads The Gastroesophageal Reflux Disease Therapeutics Market?
North America emerged as the largest region in the gastroesophageal reflux disease therapeutics market in 2024. However, the fastest growth is anticipated to occur in the Asia-Pacific region. Other regions evaluated in the report include Western Europe, Eastern Europe, South America, Middle East, and Africa.
Pre-book the report for swift delivery:
https://www.thebusinessresearchcompany.com/report/gastroesophageal-reflux-disease-therapeutics-global-market-report
What Is Covered In The Gastroesophageal Reflux Disease Therapeutics Market Global Market Report?
- Market Size Analysis: Analyze the Gastroesophageal Reflux Disease Therapeutics Market size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the Gastroesophageal Reflux Disease Therapeutics Market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall Gastroesophageal Reflux Disease Therapeutics Market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the Gastroesophageal Reflux Disease Therapeutics Market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.
Request Customization for This Report:
https://www.thebusinessresearchcompany.com/customise?id=12058&type=smp
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Booming Gastroesophageal Reflux Disease Therapeutics Market: Projected to reach $7.89 billion by 2029 with a CAGR of 6.5% here
News-ID: 3834284 • Views: …
More Releases from The Business Research Company
Global Semantic Knowledge Graphing Market Projected to Grow at 12.5% CAGR, Reach …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Semantic Knowledge Graphing Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, there has been significant growth in the market size of semantic knowledge graphing. It is anticipated that the market will expand from $1.49 billion in 2024 to $1.7 billion in 2025,…
Global Security Analytics Industry Outlook 2025-2029: Market Set to Cross $35.7 …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Security Analytics Market Through 2025?
The market size for security analytics has rapidly expanded in the recent past. From $17 billion in 2024, it is projected to swell up to $19.74 billion in 2025, representing a compound annual growth rate (CAGR) of…
Remote Work Revolution Fueling The Surge In Robotic Process Automation (RPA) Tec …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Robotic Process Automation (RPA) In Information Technology Industry Market Size Be by 2025?
The market size of Robotic Process Automation (RPA) in Information Technology has seen an explosive growth recently. The market is projected to expand from $1.42 billion in 2024 to $1.78 billion in 2025,…
Soaring Demand Set to Propel Remote Firmware Market to $13.58 Billion by 2029
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Remote Firmware Market Size By 2025?
The market size of remote firmware has experienced substantial growth in the past few years. It is projected to increase from $7.35 billion in 2024 to $8.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.8%.…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
